The University of Chicago Header Logo

Connection

Jozef Madzo to B7-H1 Antigen

Back to Details
This is a "connection" page, showing publications Jozef Madzo has written about B7-H1 Antigen.
Jozef Madzo
Connection Strength
0.050
B7-H1 Antigen
  1. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. Clin Cancer Res. 2023 06 01; 29(11):2052-2065.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.